← Back to Clinical Trials
Recruiting NCT07489443

NCT07489443 Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07489443
Status Recruiting
Phase
Sponsor University of Pittsburgh
Condition Perinatal
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2026-06-17
Primary Completion 2027-04

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Perinatal smoking cessation treatment and maintenance sessions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2026-06-17 with a primary completion date of 2027-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Using both tobacco and cannabis during pregnancy is more common in minoritized groups and can make quitting smoking in pregnancy and remaining smoke free postpartum difficult. Investigators will test an intervention to address prenatal depressive symptoms to encourage people to quit tobacco and cannabis during pregnancy and stay quit postpartum.

Eligibility Criteria

Inclusion Criteria: * Confirmed pregnant * Under 26 weeks gestation * Plan to remain pregnant * English speaking * Use of combustible tobacco at least once a week during pregnancy, or at least once a week in the 3 months before pregnancy if stopped * Use of cannabis at any frequency during pregnancy or in the 3 months before pregnancy if stopped Exclusion Criteria: * Current opioid use or active treatment for Opioid Use Disorder * Unable to provide informed consent in English * Under 18 years old

Contact & Investigator

Central Contact

Project Coordinator

✉ parentas@upmc.edu

📞 412-301-3848

Principal Investigator

Natacha De Genna

PRINCIPAL INVESTIGATOR

University of Pittsburgh

Frequently Asked Questions

Who can join the NCT07489443 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Perinatal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07489443 currently recruiting?

Yes, NCT07489443 is actively recruiting participants. Contact the research team at parentas@upmc.edu for enrollment information.

Where is the NCT07489443 trial being conducted?

This trial is being conducted at Pittsburgh, United States.

Who is sponsoring the NCT07489443 clinical trial?

NCT07489443 is sponsored by University of Pittsburgh. The principal investigator is Natacha De Genna at University of Pittsburgh. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology